Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
NCT02066792Phase 1Completed
- Start
- Apr 2014
- Primary completion
- Jul 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of d-cycloserine in Social Anxiety Disorder (SAD) (4 arms). Primary endpoint: Social Anxiety Symptom Severity at 3 months. Started Apr 2014; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02066792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066792.